CVS Health Corp. buy Biotechhunter
Summary
This prediction ended on 31.07.20 with a price of €53.59. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.85%. Dividends of €0.44 are taken into consideration when calculating the performance. Biotechhunter has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CVS Health Corp. | 3.262% | 3.262% | 58.673% | -21.878% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% | 71.506% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% | 107.710% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% | 46.809% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% | 65.323% |
Comments by Biotechhunter for this prediction
In the thread CVS Health Corp. diskutieren